Intraoperative parathyroid hormone assay during surgery for secondary hyperparathyroidism: is it time to give up the chase at the hormone?

Miccoli, Paolo
December 2012
Endocrine (1355008X);Dec2012, Vol. 42 Issue 3, p459
Academic Journal
The author discusses the fate of intraoperative parathyroid hormone therapy (PTH) during surgery for secondary hyperparathyroidism. He mentions that the technique failed to determine the cutoff for the PTH drop rate. He adds that limitations of the technique limits can influence the outcomes in patients with secondary HPT (SHPT) and tertiary HPT, where the cutoff is more difficult to determine.


Related Articles

  • Parathyroidectomy: is vitamin D a player for a good outcome? Carsote, M.; Paduraru, D. N.; Nica, A. E.; Valea, A. // Journal of Medicine & Life;Oct-Dec2016, Vol. 9 Issue 4, p348 

    Background The field of parathyroidectomy (PTx) is complex and brings together many specialists. Even if the surgical approaches changed from classical to minimally invasive PTx, a good outcome is correlated with an adeguate localization before and during PTx, while blood assays, such as...

  • Radiofrequency ablation as treatment for chronic venous insufficiency. Rubin, Susan B.; Rubin, Brian G. // JAAPA: Journal of the American Academy of Physician Assistants (;Mar2011, Vol. 24 Issue 3, p44 

    The article offers a review on the use of radiofrequency ablation (RFA) and endovenous laser ablation (EVLA) in treating chronic venous disease in the U.S. It says that laser ablation and RFA of saphenous vein are invasive surgical procedures with superb midterm and early results for patients...

  • Efficacy of cinacalcet with low-dose vitamin D in incident haemodialysis subjects with secondary hyperparathyroidism. UreƱa-Torres, Pablo; Bridges, Ian; Christiano, Cynthia; Cournoyer, Serge H.; Cooper, Kerry; Farouk, Mourad; Kopyt, Nelson P.; Rodriguez, Mariano; Zehnder, Daniel; Covic, Adrian // Nephrology Dialysis Transplantation;May2013, Vol. 28 Issue 5, p1241 

    Background Treatment with cinacalcet improves the control of secondary hyperparathyroidism (SHPT) and the achievement of calcium and phosphorus targets. Most data come from subjects receiving cinacalcet after several years of dialysis treatment. We therefore compared the efficacy of treatment...

  • Primary hyperparathyroidism: pathophysiology and impact on bone. Khan, Aliya; Bilezikian, John; Khan, A; Bilezikian, J // CMAJ: Canadian Medical Association Journal;7/25/2000, Vol. 163 Issue 2, p184 

    Primary hyperparathyroidism has been associated with bone loss, especially at cortical skeletal sites. Results from studies evaluating the mineral density of cancellous bone have been more difficult to interpret. Most densitometry studies support the concept that the parathyroid hormone appears...

  • Validity and limits of intraoperative parathyroid hormone monitoring during minimally invasive parathyroidectomy: a 10-year experience. Ozimek, Alexandra; Gallwas, J.; Stocker, U.; Mussack, T.; Hallfeldt, K. K. J.; Ladurner, R. // Surgical Endoscopy;Dec2010, Vol. 24 Issue 12, p3156 

    Background: The availability of intraoperative intact parathyroid hormone monitoring allows the success of minimally invasive parathyroidectomy to be ensured during the operation. However, false-negative results leading to unnecessary explorations and difficulties in interpreting the data raise...

  • Interpretation of Tc-99m sestamibi parathyroid SPECT-CT scans made easy for better surgical outcomes in patients with primary hyperparathyroidism. Gayed, Isis W.; Karni, Ron J.; Wan, David Q.; Varghese, Jeena M.; Wirfel, Kelly L.; Won, Kyoung S.; Joseph, Usha A. // Reports in Medical Imaging;Jan2017, Vol. 10, p1 

    Objective: This study aims to evaluate the accuracy of Tc-99m sestamibi parathyroid scan (SPS) with single-photon emission computerized tomography/computerized tomography (SPECT/CT) in patients with primary hyperparathyroidism after optimizing the interpretation of the scans with a systematic...

  • PROPRANOLOL EFFECTIVE IN SHRINKING INFANTILE HEMANGIOMA.  // Contemporary Pediatrics;Sep2011, Vol. 28 Issue 9, p11 

    The article reports a study from Australia which demonstrated that the beta-blocker popranolol is effective in shrinking infantile hemangiomas (IHs) in young children. It mentions that the study examined focal hemangiomas in 40 children up to 5 years of age. The study revealed that early...

  • Paricalcitol versus cinacalcet plus low-dose vitamin D therapy for the treatment of secondary hyperparathyroidism in patients receiving haemodialysis: results of the IMPACT SHPT study. Ketteler, Markus; Martin, Kevin J.; Wolf, Myles; Amdahl, Michael; Cozzolino, Mario; Goldsmith, David; Sharma, Amit; Marx, Steven; Khan, Samina // Nephrology Dialysis Transplantation;Aug2012, Vol. 27 Issue 8, p3270 

    Background Optimal treatment for secondary hyperparathyroidism (SHPT) has not been defined. The IMPACT SHPT (ClinicalTrials.gov identifier: NCT00977080) study assessed whether dose-titrated paricalcitol plus supplemental cinacalcet only for hypercalcaemia is superior to cinacalcet plus low-dose...

  • Effects of Calcium Carbonate, Sevelamer Hydrochloride or Pantoprazole on the Pharmacokinetics of Cinacalcet. Padhi, Desmond; Harris, Robert; Sullivan, John // Clinical Drug Investigation;Aug2014, Vol. 34 Issue 8, p537 

    Background and Objectives: Secondary hyperparathyroidism is a common consequence of chronic kidney disease. Cinacalcet (Sensipar) is often prescribed in combination to reduce elevated levels of parathyroid hormone, calcium and phosphorus. The objective of this study was to assess the effects of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics